Thus far, only case studies have reported the effects of anti-fibrotic drugs on EGFR-TKI-related ILD; however, a clinical study of this side effect of EGFR-TKI-related ILD has been planned and will finally help to develop a safer treatment regimen for EGFR-TKI-based therapy. The gene discussed is EGFR; the disease is interstitial lung disease.